SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
CHWY

Chewy, Inc. (New York Stock Exchange:CHWY)

US · Delayed Price · Currency is USD
Consumer Cyclical · Specialty Retail
21.74-0.19 (-0.87%)
 
Market cap
$8.74B
Analyst consensus
Listed since
Jun 14, 2019
Website
Insider Score
––Not scored
CHWY Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

CHWY analyst forecast

CHWY analyst consensus

Moderate Buy12 ratings
Buy 8 Hold 4 Sell 0

Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.

CHWY 12-month price target

$31.00+43.5% upsideaverage of 4 firms
$37.00High
$25.00Low

Best analysts covering CHWY

  • Raymond James67%success rate · 6 calls
  • Wedbush63%success rate · 16 calls
  • Goldman Sachs63%success rate · 8 calls
  • Baird60%success rate · 5 calls

Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.

CHWY analyst ratings

FirmPrice targetAction
—MizuhoOutperform——Reiterated2026-09-29
—JP MorganNeutral——Downgraded2026-09-11
Goldman SachsBuy$30.00+42.3%Reiterated2026-09-11
—Morgan StanleyOverweight——Reiterated2026-09-10
—RBC CapitalOutperform——Reiterated2026-09-10
—TD CowenBuy——Reiterated2026-09-10
—CitizensMarket Outperform——Reiterated2026-09-10
—BairdOutperform——Reiterated2026-09-10
—RosenblattNeutral——Reiterated2026-09-10
Evercore ISI GroupIn Line$25.00+20.5%Downgraded2026-09-10
—NeedhamHold——Reiterated2026-09-10
MizuhoOutperform$32.00+33.6%Reiterated2026-09-04
—Raymond JamesOutperform——Reiterated2026-09-04
Morgan StanleyOverweight$37.00+49.9%Reiterated2026-08-26
—RBC CapitalOutperform——Reiterated2026-08-26
—Goldman SachsBuy——Reiterated2026-06-12
—UBSNeutral——Reiterated2026-06-11
—NeedhamHold——Reiterated2026-06-11
—BairdOutperform——Reiterated2026-06-11
—CitizensMarket Outperform——Reiterated2026-06-11
—BarclaysOverweight——Reiterated2026-06-11
—TD CowenBuy——Reiterated2026-06-11
—RBC CapitalOutperform——Reiterated2026-06-11
—JP MorganOverweight——Reiterated2026-06-11
—MizuhoOutperform——Reiterated2026-06-03
—JP MorganOverweight——Reiterated2026-06-02
—BarclaysOverweight——Reiterated2026-05-26
—Morgan StanleyOverweight——Reiterated2026-05-26
—CitigroupBuy——Reiterated2026-05-12
—GuggenheimBuy——Reiterated2026-04-27
—GuggenheimBuy——Reiterated2026-04-13
—Morgan StanleyOverweight——Reiterated2026-03-31
—RBC CapitalOutperform——Reiterated2026-03-30
—CitigroupBuy——Reiterated2026-03-27
—TD CowenBuy——Reiterated2026-03-26
—CitizensMarket Outperform——Reiterated2026-03-26
—BNP ParibasNeutral——Reiterated2026-03-26
—Goldman SachsBuy——Reiterated2026-03-26
—WedbushOutperform——Reiterated2026-03-26
—GuggenheimBuy——Reiterated2026-03-26
—JP MorganOverweight——Reiterated2026-03-26
—TD CowenBuy——Reiterated2026-03-10
—Morgan StanleyOverweight——Reiterated2026-03-10
—BarclaysOverweight——Reiterated2026-03-05
—Raymond JamesOutperform——Upgraded2026-02-19
—Morgan StanleyOverweight——Reiterated2026-01-13
—Goldman SachsBuy——Reiterated2025-12-11
—NeedhamHold——Reiterated2025-12-11
—BarclaysOverweight——Reiterated2025-12-11
—UBSNeutral——Reiterated2025-12-03
—CitigroupBuy——Reiterated2025-11-24
—MizuhoOutperform——Reiterated2025-11-04
—MoffettNathansonBuy——Upgraded2025-09-25
—BairdOutperform——Reiterated2025-09-11
—WedbushOutperform——Reiterated2025-09-11
—RBC CapitalOutperform——Reiterated2025-09-11
—Morgan StanleyOverweight——Reiterated2025-09-11
—TD CowenBuy——Reiterated2025-09-11
—JP MorganOverweight——Reiterated2025-09-11
—CitigroupBuy——Reiterated2025-09-11

CHWY earnings vs. estimates

QuarterEPS est.EPS actualRevenue est.Revenue actual
2026-03-250.090.09$3.27B$3.26B
2026-06-100.240.43$3.35B$3.36B
2026-09-090.180.20$3.32B$3.33B
2026-12-090.380.00$3.34B$0
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.